- Home
- Publications
- Publication Search
- Publication Details
Title
Immunomodulation in Pediatric Asthma
Authors
Keywords
-
Journal
Frontiers in Pediatrics
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-12
DOI
10.3389/fped.2019.00289
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathophysiological Mechanisms of Asthma
- (2019) Andrew Bush Frontiers in Pediatrics
- New insights into the utility of omalizumab
- (2019) Juan Carlos Cardet et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Understanding differences in allergen immunotherapy products and practices in North America and Europe
- (2019) Vera Mahler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Asthma with multiple allergic comorbidities is associated with complete response to omalizumab
- (2019) Lucile Sesé et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Severe asthma in children
- (2019) Louise Selby et al. Current Opinion in Allergy and Clinical Immunology
- Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children
- (2019) Amelia Licari et al. RESPIRATORY MEDICINE
- EAACI guidelines on allergen immunotherapy: Executive statement
- (2018) A. Muraro et al. ALLERGY
- Cytokine-targeting biologics for allergic diseases
- (2018) Monica G. Lawrence et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- T H 1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status
- (2018) Julia A. Wisniewski et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab
- (2018) Michelle A. Gill et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Greater Treatment Benefit with Omalizumab in Children with Increased Asthma Severity: Exploratory Analyses from the Inner-City Anti-IgE Therapy for Asthma (ICATA) Study
- (2018) William W. Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy
- (2018) Erkka Valovirta et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- After asthma: redefining airways diseases
- (2018) Ian D Pavord et al. LANCET
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Asthma Endotyping and Biomarkers in Childhood Asthma
- (2018) Amelia Licari et al. Pediatric Allergy Immunology and Pulmonology
- Anti-IL-5 therapy in patients with severe eosinophilic asthma – clinical efficacy and possible criteria for treatment response
- (2018) Nora Drick et al. BMC Pulmonary Medicine
- Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population
- (2018) Amelia Licari et al. Frontiers in Pediatrics
- Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet in Japanese children
- (2018) Keisuke Masuyama et al. ALLERGY
- Efficacy and safety of omalizumab in pediatric patients with high immunoglobulin E levels: A case series
- (2018) Kathleen Y. Wang et al. ALLERGY AND ASTHMA PROCEEDINGS
- Immunotherapy and Asthma in Children
- (2018) Maria A. Tosca et al. Frontiers in Pediatrics
- Omalizumab discontinuation in children with severe allergic asthma: an observational real life study
- (2018) A Deschildre et al. ALLERGY
- “T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin
- (2018) Stelios Pavlidis et al. EUROPEAN RESPIRATORY JOURNAL
- Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma
- (2018) Sumita Khatri et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials
- (2018) Yazan Zayed et al. JOURNAL OF ASTHMA
- New approaches for identifying and testing potential new anti-asthma agents
- (2017) Amelia Licari et al. Expert Opinion on Drug Discovery
- Dupilumab for the treatment of asthma
- (2017) Giuseppe Santini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience
- (2017) Bradley E. Chipps et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Identification of IL-17F/frequent exacerbator endotype in asthma
- (2017) Fabio L.M. Ricciardolo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tezepelumab in Adults with Uncontrolled Asthma
- (2017) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omalizumab could be effective in children with severe eosinophilic non-allergic asthma
- (2017) M. Bourgoin-Heck et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Impact of omalizumab in children from a middle-income country with severe therapy-resistant asthma: A real-life study
- (2017) Paulo M. Pitrez et al. PEDIATRIC PULMONOLOGY
- Biologics and the lung: TSLP and other epithelial cell-derived cytokines in asthma
- (2017) Patrick D. Mitchell et al. PHARMACOLOGY & THERAPEUTICS
- Severe asthma in children
- (2017) Andrew Bush et al. RESPIROLOGY
- Biologic Therapy and Novel Molecular Targets of Severe Asthma
- (2017) Amber N. Pepper et al. Journal of Allergy and Clinical Immunology-In Practice
- Specific Immunotherapy in Children: The Evidence
- (2017) M La Rosa et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Characterization of asthma endotypes: implications for therapy
- (2016) Jeffrey R. Stokes et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study
- (2016) Njira Lugogo et al. CLINICAL THERAPEUTICS
- Neutrophilic and Pauci-immune Phenotypes in Severe Asthma
- (2016) Reynold A. Panettieri IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Assessment of corticosteroid response in pediatric patients with severe asthma by using a multidomain approach
- (2016) Cara J. Bossley et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
- (2016) Sally Wenzel et al. LANCET
- Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis
- (2016) Maria Kristiansen et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
- (2016) Nicola A Hanania et al. Lancet Respiratory Medicine
- Clinical contraindications to allergen immunotherapy: an EAACI position paper
- (2015) C. Pitsios et al. ALLERGY
- Real-life long-term omalizumab therapy in children with severe allergic asthma
- (2015) Antoine Deschildre et al. EUROPEAN RESPIRATORY JOURNAL
- The discovery and development of omalizumab for the treatment of asthma
- (2015) Amelia Licari et al. Expert Opinion on Drug Discovery
- From IgE to clinical trials of allergic rhinitis
- (2015) Giorgio Ciprandi et al. Expert Review of Clinical Immunology
- Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations
- (2015) Stephen J. Teach et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Targeting neutrophilic inflammation in severe neutrophilic asthma: can we target the disease-relevant neutrophil phenotype?
- (2015) P. L. B. Bruijnzeel et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The immunology of asthma
- (2015) Bart N Lambrecht et al. NATURE IMMUNOLOGY
- Systematic review on the use of omalizumab for the treatment of asthmatic children and adolescents
- (2015) Gustavo J. Rodrigo et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Christopher E Brightling et al. Lancet Respiratory Medicine
- Direct comparison of the dynamics of IL-25- and ‘allergen’-induced airways inflammation, remodelling and hypersensitivity in a murine asthma model
- (2014) X. J. Yao et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Allergen immunotherapy, routes of administration and cytokine networks: an update
- (2014) Caterina Cuppari et al. Immunotherapy
- Association of IL33–IL-1 receptor–like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood
- (2014) Olga E. Savenije et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab
- (2014) Aidan Long et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
- (2014) Gail M. Gauvreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omalizumab in Children
- (2014) Amelia Licari et al. PEDIATRIC DRUGS
- Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
- (2013) William W. Busse et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Increased IL-17A secreting CD4+T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity
- (2013) J.-W. Chien et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey
- (2013) Antoine Deschildre et al. EUROPEAN RESPIRATORY JOURNAL
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma
- (2013) Sejal Saglani et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children
- (2013) Agnes Hamzaoui et al. JOURNAL OF ASTHMA
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of IgE-Receptors in IgE-Dependent Airway Smooth Muscle Cell Remodelling
- (2013) Michael Roth et al. PLoS One
- The oral corticosteroid-sparing effect of omalizumab in children with severe asthma
- (2012) Malcolm Brodlie et al. ARCHIVES OF DISEASE IN CHILDHOOD
- The Neutrophilic Inflammatory Phenotype Is Associated With Systemic Inflammation in Asthma
- (2012) Lisa G. Wood et al. CHEST
- Omalizumab and the risk of malignancy: Results from a pooled analysis
- (2012) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- The high affinity IgE receptor (FcεRI) expression and function in airway smooth muscle
- (2012) Naresh Singh Redhu et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses
- (2011) Chris J. Corrigan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
- (2011) William W. Busse et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucocorticosteroids: current and future directions
- (2010) Peter J Barnes BRITISH JOURNAL OF PHARMACOLOGY
- Safety and tolerability of omalizumab in children with allergic (IgE-mediated) asthma
- (2010) Henry Milgrom et al. CURRENT MEDICAL RESEARCH AND OPINION
- A Large-Scale, Consortium-Based Genomewide Association Study of Asthma
- (2010) Miriam F. Moffatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma
- (2009) Sally E. Wenzel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
- (2009) Prescott G. Woodruff et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
- (2009) Bob Lanier et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started